Alerts will be sent to your verified email
Verify Email
ANTHEM
|
Anthem Biosciences
|
Syngene Internation.
|
Sai Life Sciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
25.71 % | 12.33 % | 5.08 % |
|
5yr Avg Net Profit Margin
|
28.86 % | 15.3 % | 5.05 % |
|
Price to Book
|
18.99 | 5.41 | 8.31 |
|
P/E
|
101.41 | 50.45 | 103.93 |
|
5yr Avg Cash Conversion Cycle
|
95.96 Days | -6453.7 Days | -92.7 Days |
|
5yr Average Interest Coverage Ratio
|
48.04 | 16.15 | 2.4 |
|
5yr Avg ROCE
|
33.63 % | 13.11 % | 9.14 % |
|
5yr Avg Operating Profit Margin
|
39.0 % | 29.04 % | 18.79 % |
|
5 yr average Debt to Equity
|
0.08 | 0.15 | 0.64 |
|
5yr CAGR Net Profit
|
10.71 % | 4.15 % | 22.73 % |
|
5yr Average Return on Assets
|
19.71 % | 7.88 % | 2.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.69 % | 52.68 % | 35.15 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.01 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.61 % | -0.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 17.91 % | 14.49 % |
|
Anthem Biosciences
|
Syngene Internation.
|
Sai Life Sciences
|
|---|